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Background: Trauma reactions, including post-traumatic stress disorder (PTSD), in patients with
implantable cardioverter deﬁbrillators (ICDs) have recently garnered increased attention. The aim of
this preliminary study was to examine the incidence of and risk factors for PTSD and to assess its impact
on psychosocial distress and health-related quality of life (QOL) in Japanese patients with ICD.
Methods: Seventy-four outpatients with ICD (63 men, 11 women; age 59.3713.6 years) completed a
questionnaire comprising a modiﬁed PTSD Checklist Speciﬁed for a stressor that included arrhythmias
and ICD shocks, the Zung Self-Rating Depression Scale (SDS), the State-Trait Anxiety Inventory (STAI)-
State scale, and Medical Outcomes Study 36-item Short-Form (SF-36) for health-related QOL.
We compared relevant sociodemographic and medical variables of patients with and without PTSD.
The mean number of days since ICD implantation was 24717703.
Results: Of 74 patients, 28 (37.8%) had received ICDs for secondary prevention, 42 (56.8%) had
experienced ICD shocks, 36 (48.6%) had experienced ≥1 appropriate ICD shock, and 12 (16.2%) had
experienced electrical storms. We diagnosed 19 patients (25.8%) with PTSD. Compared with the non-
PTSD group, the PTSD group had signiﬁcantly higher SDS and STAI-S scores and signiﬁcantly lower scores
in all eight subscales of the SF-36. Multiple logistic regression analysis identiﬁed experiencing ≥1
appropriate ICD shock (odds ratio [OR]: 6.0, 95% conﬁdence interval [CI]: 1.45–24.63, and po0.013) and
anxiolytic use (OR: 15.0, 95% CI: 3.38–66.26, and po0.001) as independent risk factors for PTSD.
Conclusions: Our study shows that PTSD in patients with ICD has signiﬁcant psychosocial impact with
associated impairment of both physical and mental QOL and suggests that, in particular, patients who
experience appropriate ICD shocks or take anxiolytics require psychiatric/psychological intervention.
& 2013 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Implantable cardioverter deﬁbrillators (ICD) are an established
form of therapy for both primary and secondary prevention of
lethal cardiac arrhythmias [1]. Previous studies have shown that ICD
implantation improves the quality of life (QOL) of most patients
with ICD [2,3]. However, underlying diseases or comorbidity, poor
social support, or ICD-speciﬁc problems such as frequent shocks
and poor understanding of ICD therapy can increase anxiety and
depressive symptoms and reduce QOL in patients with ICD [2,4,5].
Ten percent to 41% of the patients with ICD experience signiﬁcant
depressive symptoms, whereas general or ICD-speciﬁc anxietyt Rhythm Society. Published by Els
+81 3 3351 8979.
Nishimura).occurs in 13–38% [6]. Some preliminary studies have suggested
that psychological distress can precipitate arrhythmic events [7,8].
Moreover, a vicious cycle may ensue, characterized by ICD implan-
tation leading to anxiety and depression, which in turn precipitates
arrhythmic events, leading to further distress [9].
Recently, trauma reactions, including post-traumatic stress
disorder (PTSD), have garnered increased attention as a form of
psychosocial distress that partly overlaps depressive symptoms or
anxiety in patients with ICD [6,10–18]. According to the Diagnostic
and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
[19], PTSD occurs in people who have been exposed to a traumatic
event that involves actual or threatened death (criterion A). PTSD
symptomatology is categorized into: (1) “intrusive recollection”
(persistent re-experiencing of the traumatic event, criterion B);
(2) “avoidant/numbing” (persistent avoidance of stimuli associated
with the trauma and numbing of general responsiveness that wasevier B.V. All rights reserved.
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(persistent symptoms of increasing arousal that were not present
before the trauma, criterion D).
ICD shocks are potential traumatic stressors in patients with
ICD because they may act as continuous reminders of having a
potentially fatal disease [10,11]. Traumatic events experienced by
patients with ICD vary widely and are complex. Furthermore, even
being told that they are at risk for life-threatening arrhythmias
that could lead to sudden cardiac death (i.e., ICD implantation for
primary prevention) may be traumatic for patients [6]. Therefore,
threats to patients' lives and well-being are not isolated events,
but are persistent and enduring. Patients with PTSD symptoms
may be particularly stressed by agonizing rumination and invo-
luntary preoccupation with the underlying disease process [13].
To our knowledge, ﬁve published studies have assessed the
incidence of PTSD after ICD implantation and estimated it at 7.6–
26% [13–16]. However, these studies used disparate deﬁnitions of
criterion A of PTSD (i.e., exposure to a traumatic event that
involves actual or threatened death), presenting a methodological
problem. Some reports classiﬁed rapid onset of the cardiac condi-
tion (cardiac arrest or acute myocardial infarction) as criterion A
[13,15], whereas another used arrhythmia or its treatment (i.e.,
having an ICD) [14]. In the former, researchers excluded patients
receiving ICDs for primary prevention. To cover patients with ICDs
for both primary and secondary prevention, we believe that rapid
onset of the cardiac condition, life-threatening arrhythmia, and
ICD shocks should all separately qualify as meeting criterion A.
The aim of this preliminary study was to examine PTSD
incidence and risk factors and to assess its impact on psychosocial
distress and health-related QOL of Japanese patients with ICD.2. Method
2.1. Participants and procedures
This preliminary study was conducted as a component of routine
care in a clinical setting where patients with ICD had been
recognized as experiencing psychosocial difﬁculties. During the
4 months from February to May, 2006, collaborative care between
cardiologists and psychologists was offered to patients attending the
ICD clinic of the Department of Cardiology, Tokyo Women's Medical
University. During this period, psychologists assessed patients with
ICD for psychosocial problems. Informed consent for this assessment
was obtained from all participating patients; all were aged over 18
years and able to communicate in Japanese. The patients completed
self-completing questionnaires (in the same order for all patients) to
assess the psychological and health-related factors under investiga-
tion on the same day as their cardiological assessment. To ensure
that they did not miss any questions and to help them understand
the items, an experienced psychologist (S.K.) was present while the
patients completed the questionnaires, which took 20–30 min.
Where psychosocial problems were suspected, the psychologist
recommended that the participant receive psychosocial care. The
72 patients who completed their questionnaires during the study
period were retrospectively evaluated.
2.2. Measures
2.2.1. Assessment of post-traumatic stress symptoms
PTSD symptoms were assessed with a modiﬁed PTSD Checklist
Speciﬁed for a stressor (PCL-S) [20]. The speciﬁed stressor was
“potentially fatal cardiac arrhythmias or ICD shocks, both appro-
priate and inappropriate”. The PCL-S is a widely used, self-report-
ing, extensively validated 17-item Likert scale that corresponds to
the DSM-IV [19] criteria for PTSD. Participants were asked to ratespeciﬁc PTSD symptoms resulting from their potentially fatal
cardiac arrhythmias or ICD shocks. To make the PCL-S easier to
complete, the checklist was modiﬁed from a 5-point (“not at all”,
“a little bit”, “moderately”, “quite a bit”, and “extremely”) to a four-
point response scale (“not at all or a little of the time”, “some of
the time”, “good part of the time”, and “most of the time”) to
match the format of the other questionnaires. A presumptive PTSD
diagnosis was made when a participant met the DSM-IV symptom
criteria, namely, at least one item from criterion B (intrusive
recollection), three items from criterion C (avoidant/numbing),
and two items from criterion D (hyper-arousal). Symptoms those
were rated as “some of the time” or above (responses three
through four for individual items) were classiﬁed as present.
2.2.2. Assessment of other psychological/health-related variables
The Zung Self-Rating Depression Scale (SDS) was used to screen
for depression and to measure the severity of the depression in
numerous settings [21]. The SDS is a self-reporting scale for
assessing the psychological and somatic symptoms of depression.
It contains 20 questions and is used to assess depression in clinical
studies on cardiovascular disease [22,23].
The State-Trait Anxiety Inventory (STAI) was used to measure
anxiety symptoms [24]. As state anxiety is characterized as a
temporary change in a patient's emotional state due to medical
illness or other external cause and because state anxiety has
previously been used in clinical studies on cardiovascular disease
[25,26], only the state scale measurement was used in this study.
STAI scores range 20–80; higher scores indicate greater degrees of
anxiety.
The Medical Outcomes Study 36-item Short-Form (SF-36)
[27,28] was used to assess health-related QOL. This is a widely
used self-reporting measure of general physical and mental health
functioning across eight domains that include physical function-
ing; role-physical (limitations in the kinds/amount of work/activ-
ities due to physical functioning); bodily pain; general health;
vitality; social functioning; role-emotional (limitations in the
kinds/amount of work/activities due to emotional functioning);
and mental health. Higher scores are indicative of greater health-
related QOL. A number of validation studies have been conducted
in the general and various medically ill populations. The Japanese
version has demonstrated good reliability and validity in the
general population of Japan [27,28].
2.3. Clinical variables associated with implantable cardioverter
deﬁbrillators
Data on the relevant clinical characteristics of the participants
and the conditions under which their ICDs were implanted were
obtained from medical records. The collected data included
indications for ICDs, underlying heart disease, New York Heart
Association functional class, shock therapy history (times of
shocks, both appropriate and inappropriate; electrical storm [ES]
experiences, deﬁned as the occurrence of ≥3 separate episodes of
ventricular tachycardia or ventricular ﬁbrillation within 24 h; days
since ICD implantation; days since last shock), medications, living
with/without family, and employment status.
2.4. Statistical analyses
Student's t-test was used to identify differences in continuous
variables between groups, and categorical variables were com-
pared by the χ2 test. To identify independent risk factors for PTSD,
the variables were analyzed in two steps. In the ﬁrst step,
univariate analysis was performed. In the second step, multiple
logistic regression analysis was performed, with forward stepwise
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signiﬁcantly (po0.05) or almost signiﬁcantly (po0.25) associated
with the PTSD group were used in the ﬁrst step. Regression
coefﬁcients were used to calculate the odds ratio (OR) and 95%
conﬁdence interval (CI) of the OR. In all statistical analyses,
po0.05 was taken to indicate statistical signiﬁcance. Data ana-
lyses were performed by using SPSS (version 16, SPSS, Chicago,
IL, USA).3. Results
3.1. Relevant clinical and other characteristics of participants
The relevant clinical and other characteristics of the study
group are listed in Table 1. In all, 74 patients (63 men and 11
women; age, 59714 years [mean7SD]) completed the surveys.
Eight patients (11%) lived alone and 35 (47%) were not working at
the time of the survey. The underlying heart disease was coronary
artery disease in 19% of cases. Twenty-eight patients (38%) under-
went ICD implantation for secondary prevention. The mean
number of days since ICD implantation was 24717703 days. Of
the 74 patients, 42 (57%) had experienced ICD shocks and 12 (16%),
ES. No patients in had received non-pharmacological therapy,Table 1
Characteristics of subjects with or without PTSD.
Overall (n¼74)
Male 63(85.1)
Age in years 59.3713.6
Indication for ICD
Primary prevention 46(62.2)
Secondary prevention 28(37.8)
Underlying heart disease
Coronary artery disease 14(18.9)
Idiopathic dilated cardiomyopathy 14(18.9)
Hypertrophic cardiomyopathy 11(14.9)
Arrhythmogenic right ventricular cardiomyopathy 2(2.7)
Unclassiﬁed cardiomyopathy 2(2.8)
Valvular heart disease 3(4.1)
Idiopathic VF/long QT syndrome 22(29.7)
Others 6(8.1)
NYHA functional class
I 51(68.9)
II 22(29.7)
III 1(1.4)
Clinical variance
≥1 ICD shock, total* 42(56.8)
≥1 ICD shock, appropriate 36(48.6)
≥1 ICD shock, inappropriate, never appropriate 6(8.1)
Number of shocks (in those receiving shocks) 13.5(21.7)
≥1 Electrical storm 12(16.2)
Days since ICD implantation 2471.27702.5
Days since last shock
Medications
β-Blockers 35(47.3)
ACE inhibitors/ARBs 36(48.6)
Amiodarone/sotalol 34(37.8)
Antidepressants 4(5.4)
Anxiolytics 15(20.3)
Hypnotics 10(13.5)
Not living with family 8(10.8)
Unemployed/retired 35(47.3)
Values indicate number of patients (%) or the mean7SD.
ACE, angiotensin-converting enzyme; ARB, angiotension II receptor blocker; ICD, im
post-traumatic stress disorder; and VF, ventricular ﬁbrillation.
n Appropriate and inappropriate shocks.such as cognitive behavioral therapy (CBT), for any psychiatric
condition.
3.2. Incidence of post-traumatic stress disorder and its effect on
psychological distress and health-related quality of life
Nineteen of the 74 patients (25.8%) were diagnosed with PTSD.
The incidence of PTSD according to the indication for ICD and ICD
shock experience is shown in Fig. 1. No differences in incidence of
PTSD were found between patients who received ICD for primary
prevention and those who received ICD for secondary prevention
(Table 1). Remarkably, of the 21 patients with ICDs for primary
prevention who had never experienced ICD shocks, four (21.1%)
were diagnosed with PTSD.
Analyses of SDS and STAI-S scores as well as the eight subscales
of the SF-36 are shown in Table 2. Compared with the non-PTSD
group, the PTSD group had signiﬁcantly higher SDS and STAI-S
scores and signiﬁcantly lower scores in all eight subscales of the
SF-36.
3.3. Risk factors for post-traumatic stress disorder
Table 1 also lists the results of the univariate analysis per-
formed in the ﬁrst step to identify risk factors for PTSD. ComparedPTSD (n¼19) No PTSD (n¼55) p
18(94.7) 45(81.8) 0.16
61.3711.8 58.6714.2 0.47
14(73.7) 32(58.2)
5(26.3) 23(41.8) 0.18
4(21.1) 10(18.2)
5(26.3) 9(16.4)
4(21.1) 7(12.7)
0(0.0) 2(3.6)
1(5.3) 1(1.8)
2(10.5) 1(1.8)
3(15.8) 19(34.5)
0(0.0) 6(10.9) 0.28
10(52.6) 41(74.5)
8(42.1) 14(25.5)
1(5.3) 0(0.0) 0.03
14(73.7) 28(50.9) 0.07
14(73.7) 22(40.0) 0.01
0(0.0) 6(10.9) 0.33
12.3(22.2) 6.1(15.6) 0.13
8(42.1) 4(7.2) 0.00
25197727.5 24547699.6 0.73
806.47749.6 122671018.3 0.18
10(52.6) 25(45.5) 0.39
9(47.4) 27(49.1) 0.56
11(57.9) 23(41.8) 0.17
3(15.8) 1(1.8) 0.05
10(52.6) 5(9.1) 0.00
5(26.3) 5(9.1) 0.07
3(15.8) 5(9.1) 0.33
13(68.4) 22(40.0) 0.09
plantable cardioverter deﬁbrillator; NYHA, New York Heart Association; PTSD,
PTSD
n = 19 (25.7%)
ICD Shock
Indication
Overall n = 74
Primary
n = 46
No
n = 21
Yes
n = 25
Secondary
n = 28
No
n = 11
Yes
n = 17
YES
n = 4
YES
n = 10
YES
n = 1
YES
n = 4
No
n = 17
No
n = 10
No
n = 13
No
n = 15
Fig. 1. The prevalence of PTSD according to indications for ICD and ICD shock
experience. ICD, implantable cardioverter deﬁbrillator and PTSD, post-traumatic
stress disorder.
Table 2
Scores for psychological distress and health-related QOL with and without PTSD.
Overall
(n¼74)
PTSD
(n¼19)
No PTSD
(n¼55)
t p
SDS 39.7710.4 48.578.4 36.379.1 5.05 0.00
STAI-state 41.6712.7 49.1714.0 39.0711.2 3.17 0.00
SF-36
Physical
functioning
71.5722.3 61.9717.5 74.6722.9 2.15 0.04
Role physical 73.5727.2 57.0728.8 79.1724.5 3.17 0.00
Bodily pain 74.9725.0 65.8722.7 77.9725.2 1.81 0.08
General health 46.5719.0 32.4715.2 51.1717.9 3.98 0.00
Vitality 58.9719.8 47.4716.3 62.4719.5 2.86 0.01
Social
functioning
71.1727.0 52.1728.8 77.3723.5 3.73 0.00
Role emotional 74.6726.6 56.9726.4 80.8724.1 3.53 0.00
Mental health 70.7721.3 52.2718.0 76.7718.6 4.85 0.00
PTSD, post-traumatic stress disorder; SDS, Zung Self-Rating Depression Scale;
SF-36, Medical Outcomes Study 36-item Short-Form; and STAI, State-Trait Anxiety
Inventory.
Table 3
Logistic regression analysis of risk factors for PTSD.
Variable B p Odds ratio 95% Conﬁdence interval
Anxiolytic use 2.706 0.013 14.98 3.38–66.26
≥1 appropriate ICD shock 1.787 0.000 5.97 1.45–24.63
2 log likelihood¼62.092; χ2¼22.214 (po0.0001); and Nagelkerke R2¼0.381.
PTSD, Post-traumatic stress disorder and ICD, implantable cardioverter deﬁbrillator.
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New York Heart Association functional class (po0.028), more
frequent ES (po0.001), experienced ≥1 appropriate ICD shocks
(po0.01), and more frequent use of antidepressants (po0.05) and
anxiolytics (po0.0001). According to multiple logistic regression
analysis, experiencing ≥1 appropriate ICD shock and anxiolytic use
were signiﬁcant independent risk factors (Table 3). The OR for
experiencing ≥1 appropriate ICD shock was 6.0 (95% CI: 1.45–
24.63, and po0.013); that for anxiolytic use was 15.0 (95% CI:
3.38–66.26, and po0.001).4. Discussion
This cross-sectional study obtained three major ﬁndings.
First, the incidence of PTSD, estimated by using the modiﬁed
PCL-S for cardiac arrhythmia or ICD shock, was 25.8% in Japanese
patients with ICD. Second, the PTSD was associated with signiﬁ-
cantly impaired QOL in patients with ICD for both physical and
mental subscales. Third, independent risk factors for PTSD were
experiencing ≥1 appropriate ICD shock and anxiolytic use. To our
knowledge, this is the ﬁrst study to evaluate PTSD in Japanese
patients with ICD.4.1. Incidence of post-traumatic stress disorder in patients with
implantable cardioverter deﬁbrillators
Five studies estimated the incidence of PTSD in patients with
ICD to be 7.6–26% [13–17]. This variation may be caused by several
factors, including PTSD diagnostic procedure and study population
characteristics such as underlying disease. In the United States, the
underlying diseases in 81% of patients with ICD are ischemic heart
diseases such as myocardial infarction or angina pectoris, whereas
in Japan, the underlying diseases in patients with ICD are ischemic
heart diseases, cardiomyopathies, and idiopathic ventricular ﬁbril-
lation (arrhythmia) in 34%, 35%, and 19%, respectively [29]. In the
present study, 38% of the participants received ICDs for secondary
prevention. Of the 28 patients who received ICDs for secondary
prevention, ﬁve developed PTSD. This ﬁnding appears consistent
with those of previous studies of patients with ICDs for secondary
prevention: 26% in the Living with an Implanted Cardioverter
Deﬁbrillator study [13] or 19% at baseline (average of 2 years after
implantation) and 12% at ﬁnal follow-up (5.5 years) in a long-
itudinal study [15]. As was true of our study, Kapa et al. studied
patients with ICD with both primary and secondary prevention
indications (51% for secondary) [14]. They found that the incidence
of PTSD at 2, 6, and 12 months after implantation was 21%, 12%,
and 13%, respectively.
The diagnostic procedure for PTSD also affects the apparent
incidence of PTSD. It remains controversial whether patients who
have received ICDs for primary prevention and have not experi-
enced ICD shocks meet criterion A for a PTSD diagnosis (exposure
to a traumatic and life-threatening event) [19]. However, in the
present study, 4/21 (19%) of such patients did develop PTSD.
Despite the small number of subjects, this ﬁnding suggests that
even being told that they are at risk of life-threatening arrhyth-
mias and having an ICD implanted may result in the development
of PTSD symptoms in some patients. PTSD occurring after receiv-
ing diagnoses of other life-threatening diseases such as HIV [30]
has been reported.
The gold standard for diagnosing PTSD is a structured clinical
interview such as the Clinician-Administered PTSD Scale [31].
However, in all previous studies evaluating PTSD in patients with
ICD, self-reporting questionnaires such as the Impact of Events
Scale-Revised [13–15,32] or the Post-traumatic Stress Diagnostic
Scale [16,17,33] have been used to make a presumptive diagnosis.
Although the PCL-S used in this study reﬂects the DSM-IV
symptoms of PTSD, it also provides only a presumptive diagnosis.
Further studies using a structured interview procedure for a more
accurate PTSD diagnosis are needed.4.2. Factors associated with post-traumatic stress disorder
The following key risk factors for depression or anxiety in
patients with ICD have been identiﬁed: o50 years of age, being
female, premorbid psychiatric diagnosis, poor social support, and
45 deﬁbrillations (appropriate or inappropriate) [6]. However,
information on the risk factors for PTSD in such patients has been
limited.
Table 4
PTSD symptom clusters and presentation in patients with ICDc.
Criterion A (exposure): All
 Cardiac event, SCAa, ICDb implantation, shock, or electrical storm is perceived as deadly or threatening
 There is a perception of fear, helplessness, or horror
Criterion B (persistent re-experiencing): ≥1
 Recalling the cardiac event repeatedly
 Dreaming about getting shocked
 Truly believing or feeling shock is recurring (e.g., phantom shock)
 Exposure to cues that remind them of the event (e.g., couch they were on when shocked) creates psychological distress
 Exposure to cues that remind them of the event (e.g. heart racing) causes the body to react
Criterion C (persistent avoidance): ≥3
 Avoiding discussion of the event (this may include avoidance of an ofﬁce visit or repeated no-shows)
 Cannot remember the event (e.g., SCA or shock)
 Avoidance of engagement in activities because of fear of shock
 Feeling estranged from family or friends following cardiac trauma
 Restricted range of affect (inability to express a range of emotions) following SCA or shock
 Belief that shock is an indicator of cardiac health and foreshortened future
Criterion D (increased arousal): ≥2
 Following cardiac trauma (e.g., surgery, SCA, shock, electrical storm)
 Trouble falling or staying asleep
 More irritable and angry
 Difﬁculty concentrating
 Exaggerated startle response
 Hyper-vigilant: preoccupied with heart rate, gastrointestinal and chest pain, and other bodily sensations
a SCA, sudden cardiac arrest.
b ICD, implantable cardioverter-deﬁbrillator.
c Modiﬁed from Sears et al. [6].
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evaluated in ﬁve studies [13–17]; their ﬁndings are controversial.
In three of the ﬁve studies, ICD shocks were associated with PTSD
diagnoses [14–16]. Kapa et al. found that patients who had
experienced ES had signiﬁcantly higher PTSD scores within
2 months after implantation; however, they reported no difference
in PTSD scores between patients who had experienced appropriate
ICD shocks and those who had not [14]. Von Kanel et al. found that
experiencing at least ﬁve ICD shocks (appropriate or inappropri-
ate) was a predictor of PTSD [15]. Versteeg et al. found that ICD
shock (appropriate or inappropriate) was the strongest determi-
nant of PTSD at 3 months post-implantation, but was not asso-
ciated with PTSD at 6 months post-implantation.
The role of inappropriate ICD shocks on the development
of PTSD was not evaluated in the ﬁve studies mentioned above
[13–17]. In the present study, inappropriate ICD shocks were not
associated with PTSD. Due to the possibility of various backgrounds
being associated with the development of PTSD, a more accurate
role of ICD therapy as the cause of PTSD should be evaluated in
different study designs, including a control population.
Psychological distress, especially PTSD symptoms, evokes sym-
pathetic nervous system activity, which might be a trigger for a
lethal arrhythmia. Although depression has been reported as a
predictor for appropriate shocks (subsequent occurrence of lethal
arrhythmias) among patients with ICD [34]; such a predictive effect
of PTSD remains unknown. In the present study, experiencing ≥1
appropriate ICD shock was associated with PTSD, but a causal
relationship cannot be inferred from this cross-sectional study.
In addition, we identiﬁed anxiolytic use as an independent risk
factor. Versteeg et al. and Habibovic et al. found that baseline
anxiety predicts PTSD independently [16,17]. Subjective cardiac
symptoms [13] or ICD concerns [16] are reportedly associated with
PTSD. It is reasonable to presume that anxiety or perceived
sensitivity to cardiac conditions may lead to the subsequent pre-
scription of anxiolytics. First-line standard pharmacologic treatment
for PTSD is a selective serotonin reuptake inhibitor (SSRI), not an
anxiolytic [35]. Furthermore, non-pharmacologic treatment such as
CBT is generally effective for PTSD [36], and may be useful forpatients with ICD [37,38]. Although the effect of SSRIs on decreasing
ICD intervention is unknown, preliminary studies have reported
that a SSRI [39] or SSRI in combination with CBT [40] is associated
with reduced ventricular arrhythmia in patients with ICD.
Clinicians need to consider the possibility of PTSD; it is
desirable to consult psychiatrists when it is suspected. We have
provided examples of how PTSD symptoms may be expressed in
patients with ICD according to the description of Sears et al. [6]
(Table 4). Formal diagnosis requires that the disturbance (symp-
toms in criteria B, C, and D) last longer than 1 month and cause
clinically signiﬁcant distress or impairment in social, occupational,
or other important areas of functioning [19].4.3. Limitations of this study
This preliminary study has several limitations. First, there were
possible design ﬂaws in that it did not enroll consecutive patients,
which may have created bias. Moreover, it was retrospective, of
cross-sectional design, and involved a single center. Second, we
used a modiﬁed version of the PCL-S, a self-reporting question-
naire, as a diagnostic tool. As explained in Section 4.1, this tool
only provides a presumptive diagnosis. Furthermore, modiﬁcation
of the PCL-S may have inﬂuenced its discriminant properties.
Third, because the number of subjects in this study was relatively
small, subgroup analysis was not feasible. To clarify these issues,
we suggest that further prospective clinical investigations, includ-
ing a control population, must be carried out.5. Conclusions
The present preliminary study shows that PTSD has a signiﬁ-
cant psychosocial impact with associated impairment of both
physical and mental QOL in patients with ICD. In particular, our
ﬁndings suggest that patients who have experienced appropriate
ICD shocks or are taking anxiolytics require psychiatric/psycho-
logical intervention.
S. Kobayashi et al. / Journal of Arrhythmia 30 (2014) 105–110110Conﬂict of interest
None of the authors has any conﬂicts of interest to declare.Acknowledgments
The authors thank Professors Nobuhisa Hagiwara, Morio Shoda,
and Hiroshi Kasanuki for helpful suggestions and support, and
thank Drs. Kazue Kuwahara, Naoki Matsuda, and Kohei Tanizaki
for their support and assistance.
References
[1] Goldberger Z, Lampert R. Implantable cardioverter-deﬁbrillators. Expanding
indications and technologies. JAMA 2006;295:809–18.
[2] Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients.
Heart 2002;87:488–93.
[3] Spurrell P, Mitchell A, Kamalvand K, et al. Quality of life after use of the
patient activated atrial deﬁbrillator. Int J Clin Pract 2003;57:30–4.
[4] Thomas SA, Friedmann E, Kao CW, et al. Quality of life and psychological
status of patients with implantable cardioverter deﬁbrillators. Am J Crit Care
2006;15:389–98.
[5] Jacq F, Foulldrin G, Savouré A, et al. A comparison of anxiety, depression, and
quality of life between device shock and nonshock groups in implantable
cardioverter deﬁbrillator recipients. Gen Hosp Psychiatry 2009;31:266–73.
[6] Sears SF, Hauf JD, Kirian K, et al. Posttraumatic stress and the implantable
cardioverter-deﬁbrillator patient: what the electrophysiologist needs to know.
Circ Arrhythmia Electrophysiol 2011;4:242–50.
[7] Whang W, Albert CM, Sears Jr. SF, et al. Depression as a predictor for
appropriate shocks among patients with implantable cardioverter-deﬁbrilla-
tors: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am
Coll Cardiol 2005;45:1090–5.
[8] Heller SS, Ormont MA, Lidagoster L, et al. Psychosocial outcome after ICD
implantation: a current perspective. Pacing Clin Electrophysiol
1998;21:1207–15.
[9] Pedersen SS, Van den Broek KC, Sears SF. Psychological intervention following
implantation of an implantable deﬁbrillator: a review and future recommen-
dations. Pacing Clin Electrophysiol 2007;30:1546–54.
[10] Hamner M, Hunt N, Gee J, et al. PTSD and automatic implantable cardioverter
deﬁbrillators. Psychosomatics 1999;40:82–5.
[11] Neel M. Posttraumatic stress symptomatology in patients with automatic
implantable cardioverter deﬁbrillators: nature and intervention. Int J Emer-
gency Ment Health 2000;2:259–63.
[12] Prudente LA, Reigle J, Bourguignon C, et al. Psychological indices and phantom
shocks in patients with ICD. J Interventional Card Electrophysiol 2006;5:185–90.
[13] Ladwig KH, Baumert J, Marten-Mittag B, et al. Posttraumatic stress symptoms
and predicted mortality in patients with implantable cardioverter-deﬁbrilla-
tors: results from the prospective living with an implanted cardioverter-
deﬁbrillator study. Arch Gen Psychiatry 2008;65:1324–30.
[14] Kapa S, Rotondi-Trevisan D, Mariano Z, et al. Psychopathology in patients with
ICDs over time: results of a prospective study. Pacing Clin Electrophysiol
2010;33:198–208.
[15] von Kanel R, Baumert J, Kolb C, et al. Chronic posttraumatic stress and its
predictors in patients living with an implantable cardioverter deﬁbrillator. J
Affect Disord 2010;31:344–52.
[16] Versteeg H, D.A.M.J. Theuns, Erdman RAM, et al. Posttraumatic stress in
implantable cardioverter deﬁbrillator patients: the role of preimplantation
distress and shocks. Int J Cardiol 2011;3:438–9.
[17] Habibović M, van den Broek KC, Alings M, et al. Posttraumatic stress 18
months following cardioverter deﬁbrillator implantation: shocks, anxiety, and
personality. Health Psychol 2012;31:186–93.
[18] Bilanovic A, Irvine J, Kovacs AH, et al. Uncovering phantom shocks in cardiac
patients with an implantable cardioverter deﬁbrillator. Pacing Clin Electro-
physiol 2013;36:673–83.[19] American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders. 4th ed. Washington: American Psychiatric Association;
1994 ([Revised]).
[20] Weathers F.W., Litz B.T., Herman D.S., et al., The PTSD checklist: reliability,
validity, & diagnostic utility. Paper presented at the Annual Meeting of the
International Society for Traumatic Stress Studies, San Antonio, Texas; 1993.
[21] W.W.K. Zung. A self-rating depression scale. Arch Gen Psychiatry
1965;12:63–70.
[22] Shiotani I, Sato H, Kinjo K, et al. The Osaka Acute Coronary Insufﬁciency Study
(OACIS) group. Depressive symptoms predict 12-month prognosis in elderly
patients with acute myocardial infarction. J Cardiovasc Risk 2002;9:153–60.
[23] Pihl E, Jacobsson A, Fridlund B, et al. Depression and health-related quality of
life in elderly patients suffering from heart failure and their spouses: a
comparative study. Eur J Heart Fail 2005;7:583–9.
[24] Spielberger CD, Gorssuch RL, Lushene PR, et al. Manual for the State-Trait
Anxiety Inventory. Palo Alto: Consulting Psychologists Press; 1983.
[25] Kamphuis HC, de Leeuw JR, Derksen R, et al. Implantable cardioverter
deﬁbrillator recipients: quality of life in recipients with and without ICD
shock delivery: a prospective study. Europace 2003;5:381–9.
[26] van den Broek KC, Nyklícek I, van der Voort PH, et al. Risk of ventricular
arrhythmia after implantable deﬁbrillator treatment in anxious type D
patients. J Am Coll Cardiol 2009;54:531–7.
[27] Fukuhara S, Bito S, Green J, et al. Translation, adaptation, and validation of the
SF-36 Health Survey for use in Japan. J Clin Epidemiol 1998;5:1037–44.
[28] Fukuhara S, Ware JE, Kosinski M, et al. Psychometric and clinical tests
of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol
1998;51:1045–53.
[29] The Japanese Circulation Society, The Japanese Association for Thoracic
Surgery, The Japanese Society for Artiﬁcial Organs, The Japanese Society for
Cardiovascular Surgery, The Japanese College of Cardiology, The Japanese
Society of Electrocardiology, The Japanese Heart Failure Society, The Japanese
Heart Rhythm Society. Guidelines for the Diagnosis and Treatment of
Cardiovascular Diseases; 2005.
[30] Nightingale VR, Sher TG, Mattson M, et al. The effects of traumatic stressors
and HIV-related trauma symptoms on health and health related quality of life.
AIDS Behav 2011;15:1870–8.
[31] Blake DD, Weathers FW, Nagy LM, et al. The development of a Clinician-
Administered PTSD Scale. J Traumatic Stress 1995;8:75–90.
[32] Weiss DS, Marmar CR. The impact of event scale-revised. In: Wilson J, Keane T,
editors. Assessing Psychological Trauma and PTSD. New York: Guilford; 1997
pp. 344–62.
[33] Foa E, Cashman L, Jaycox L, et al. The validation of a self-report measure of
posttraumatic stress disorder: the posttraumatic diagnostic scale. Psychol
Assess 1997;9:445–51.
[34] Whang W, Albert CM, Sears Jr. SF, et al. Depression as a predictor for
appropriate shocks among patients with implantable cardioverter-deﬁbrilla-
tors: results from the Triggers of Ventricular Arrhythmias (TOVA) study. J Am
Coll Cardiol 2005;45:1090–5.
[35] Stein DJ, Ipser J, McAnda N. Pharmacotherapy of posttraumatic stress disorder:
a review of meta-analyses and treatment guidelines. CNS Spectrums 2009;14
(1 Suppl 1):25–31.
[36] Mendes DD, Mello MF, Ventura P, et al. A systematic review on the
effectiveness of cognitive behavioral therapy for posttraumatic stress disorder.
Int J Psychiatry Med 2008;38:241–59.
[37] Frizelle DJ, Lewin RJP, Kaye G, et al. Cognitive-behavioral rehabilitation
programme for patients with an implanted cardioverter deﬁbrillator: a pilot
study. Brit J Health Psychol 2004;9:381–92.
[38] Sears SF, Sowell LDV, Kuhl EA, et al. The ICD shock and stress management
program: a randomized trial of psychosocial treatment to optimize quality of
life in ICD patients. Pacing Clin Electrophysiol 2007;30:858–64.
[39] Leftheriotis D, Flevari P, Ikonomidis I, et al. The role of the selective serotonin
re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic
heart failure: a preliminary study. Pacing Clin Electrophysiol 2010;33:1217–23.
[40] Kuijpers PM, Honig A, Wellens HJ. Effect of treatment of panic disorder in
patients with frequent ICD discharges: a pilot study. Gen Hosp Psychiatry
2002;24:181–4.
